Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |